Pazopanib Maintenance for SCLC

NCT01797874 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

97

Enrollment

OTHER

Sponsor class

Conditions

SCLC

Interventions

DRUG: Pazopanib
DRUG: Placebo

Sponsor

Samsung Medical Center